Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the ...

Non-Alcoholic Fatty Liver Disease (NAFLD) is emerging as a significant global health concern, driven by increasing rates of obesity, diabetes and sedentary lifestyles. NAFLD includes a spectrum of ...

The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...

It also increases risk for liver cancer. Nature journal explains meeting of a healthy liver, NAFLD, NASH and Cirrhosis. NAFLD often has no symptoms. When it does, they may include fatigue ...

Add articles to your saved list and come back to them any time. Peter Nash was only two years old in 1935 when his father, first class constable Leslie Andrew Nash, was discovered dead in the ...

For those with fatty liver disease, combining raw turmeric with beverages may serve as an organic complementary therapy. Below are four raw turmeric beverages that can potentially heal and shield ...

Two in 5 US adults (approximately 122 million) will have metabolic dysfunction–associated steatotic liver disease (MASLD) by 2050, with a concurrent increase in liver cancer, cirrhosis, and need ...

Ten small-molecule drugs associated with COPD and NASH were identified through cMAP analysis, including ansoprazole and atovaquone. In addition, we further identified the hub genes S100A9 and MYH2 for ...

A new study has revealed that About 84 per cent of the IT employees in India are suffering from Metabolic Dysfunction-Associated Fatty Liver Disease ... includes a wide spectrum of liver injury ...

It encompasses a spectrum of diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH) and can progress to fibrosis, cirrhosis, and hepatocellular carcinoma. The global ...